10.11

2.79% -0.29

After Hours: 10.23 0.12 +1.19%

Ginkgo Bioworks Holdings Inc (DNA)

Overview News Price History Option Chain Why DNA Down? Discussions Forecast

Ginkgo Bioworks Holdings Inc stock is traded at $10.11, with a volume of 1.39M. It is down -2.79% in the last 24 hours and up +22.99% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Previous Close:

$10.40

Open:

$10.24

24h Volume:

1.39M

Relative Volume:

1.09

Market Cap:

$660.43M

Revenue:

$141.31M

Net Income/Loss:

$-297.87M

P/E Ratio:

-1.8745

EPS:

-5.3933

Net Cash Flow:

$-168.20M

1W Performance:

-0.98%

1M Performance:

+22.99%

6M Performance:

+10.25%

1Y Performance:

-20.52%

1-Day Range:

$9.70

$10.58

1-Week Range:

$9.66

$11.14

52-Week Range:

$5.37

$17.58

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name

Ginkgo Bioworks Holdings Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

(877) 442-5362

Address

27 DRYDOCK AVENUE, BOSTON

Employee

485

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

DNA's Discussions on Twitter

Compare DNA vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DNA Ginkgo Bioworks Holdings Inc	10.11	647.37M	141.31M	-297.87M	-168.20M	-5.3933
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight
May-18-22	Downgrade	BofA Securities	Neutral → Underperform
Mar-02-22	Resumed	Cowen	Outperform
Feb-23-22	Initiated	Goldman	Neutral
Feb-01-22	Initiated	BofA Securities	Neutral
Jan-28-22	Initiated	BofA Securities	Buy
Jan-07-22	Initiated	BTIG Research	Buy
Nov-29-21	Initiated	Jefferies	Buy
Oct-13-21	Initiated	Raymond James	Outperform
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy

View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

Jun 29, 2026

Ginkgo Bioworks Holdings, Inc.(NYSE:DNA) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Ginkgo Bioworks Holdings, Inc.(NYSE: DNA) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026

Ginkgo Bioworks Holdings, Inc.(NYSE:DNA) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 28, 2026

Palantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think - The Motley Fool

Jun 28, 2026

Ginkgo Bioworks (DNA) Q1 2026 Earnings: EPS Misses Estimates, Stock Surges Over 7%Buyback Announcement Report - dars.gov.et

Jun 28, 2026

Jun 27, 2026

Enterprise value to revenue forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 27, 2026

Price to earnings forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 27, 2026

Enterprise value to EBIT forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 27, 2026

Enterprise value to EBITDA forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 27, 2026

Jun 26, 2026

Price to sales forward of Ginkgo Bioworks Holdings, Inc. – NYSE:DNA - TradingView

Jun 26, 2026

Jun 25, 2026

Ginkgo Bioworks Holdings, Inc. Class A Actuals & Estimates (NYSE:DNA) - TradingView

Jun 25, 2026

9L40 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Price to sales forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView

Jun 25, 2026

Price to earnings forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView

Jun 25, 2026

Price to book forward of Ginkgo Bioworks Holdings Inc. – OTC:DNABW - TradingView

Jun 25, 2026

DNA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 23, 2026